A detailed history of First National Advisers, LLC transactions in Enovis Corp stock. As of the latest transaction made, First National Advisers, LLC holds 8,727 shares of ENOV stock, worth $395,769. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,727
Previous 8,048 8.44%
Holding current value
$395,769
Previous $363,000 3.31%
% of portfolio
0.06%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$40.57 - $48.1 $27,547 - $32,659
679 Added 8.44%
8,727 $375,000
Q2 2024

Aug 13, 2024

BUY
$44.56 - $62.43 $99,725 - $139,718
2,238 Added 38.52%
8,048 $363,000
Q1 2024

May 15, 2024

BUY
$55.44 - $63.8 $322,106 - $370,678
5,810 New
5,810 $362,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.45B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track First National Advisers, LLC Portfolio

Follow First National Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First National Advisers, LLC with notifications on news.